127 related articles for article (PubMed ID: 2900598)
1. New ranitidine analogues containing the 2-aminobenzimidazole moiety: in vivo and in vitro histamine H2-receptor blocking activity.
Orsetti M; Oggero L
Agents Actions; 1988 Jun; 24(1-2):109-13. PubMed ID: 2900598
[TBL] [Abstract][Full Text] [Related]
2. Histamine H2-receptor blocking activity of ranitidine and lamtidine analogues containing aminomethyl-substituted aliphatic systems.
Orsetti M
Agents Actions; 1988 Dec; 25(3-4):291-5. PubMed ID: 2905866
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological profile of new histamine H2-receptor antagonists related to cimetidine, ranitidine and lamtidine.
Orsetti M; Sorba G
J Pharm Pharmacol; 1988 Jan; 40(1):31-4. PubMed ID: 2896770
[TBL] [Abstract][Full Text] [Related]
4. Some in vitro and in vivo actions of the new histamine H2-receptor antagonist, ranitidine.
Daly MJ; Humphray JM; Stables R
Br J Pharmacol; 1981 Jan; 72(1):49-54. PubMed ID: 6112034
[TBL] [Abstract][Full Text] [Related]
5. Characterization of an accessory binding area in the histamine H2 receptor.
Orsetti M; Sorba G
Eur J Pharmacol; 1991 Jul; 207(3):259-65. PubMed ID: 1680063
[TBL] [Abstract][Full Text] [Related]
6. Histamine H2-receptor blocking activity of ranitidine analogues containing 3-amino-4-alkylaminofurazan moieties.
Orsetti M; Oggero L; Sorba G
Pharmacol Res; 1989; 21(1):115-6. PubMed ID: 2566988
[No Abstract] [Full Text] [Related]
7. FR145715, a novel histamine H2 receptor antagonist, with specific anti-Helicobacter pylori activities.
Ishikawa H; Ito H; Higaki M; Higaki M; Matsumoto Y; Kamimura T; Katsura Y; Tomishi T; Inoue Y; Takasugi H; Tomoi M; Krakowka S; Yoshida K
Eur J Pharmacol; 1999 Aug; 378(3):299-310. PubMed ID: 10493106
[TBL] [Abstract][Full Text] [Related]
8. Activity of the new histamine H2-receptor antagonist zolantidine at cardiac and gastric H2-receptors.
Coruzzi G; Adami M; Pozzoli C; Poli E; Bertaccini G
Pharmacology; 1994 Feb; 48(2):69-76. PubMed ID: 7907797
[TBL] [Abstract][Full Text] [Related]
9. Potential histamine H2-receptor antagonists. Synthesis, structure and activity of a few open models related to classical H2-antagonists.
Sorba G; Fruttero R; Gasco A; Orsetti M
Arzneimittelforschung; 1989 Sep; 39(9):1092-6. PubMed ID: 2574039
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology of JB-9315, a new selective histamine H2-receptor antagonist.
Palacios B; Montero MJ; Sevilla MA; San Román L
Gen Pharmacol; 1998 Feb; 30(2):181-9. PubMed ID: 9502172
[TBL] [Abstract][Full Text] [Related]
11. Pharmacology of mifentidine, a novel H2-receptor antagonist.
Pagani F; Micheletti R; Brambilla A; Schiavone A; Montagna E; Ciprandi C; Giachetti A
Arzneimittelforschung; 1985; 35(1A):451-5. PubMed ID: 2859036
[TBL] [Abstract][Full Text] [Related]
12. A review of the animal pharmacology of ranitidine--a new, selective histamine H2-antagonist.
Brittain RT; Daly MJ
Scand J Gastroenterol Suppl; 1981 Jun; 69():1-9. PubMed ID: 6119770
[TBL] [Abstract][Full Text] [Related]
13. Cardiac and gastric effects of histamine H2 receptor antagonists: no evidence for a correlation between lipophilicity and receptor affinity.
Coruzzi G; Adami M; Pozzoli C; Giorgi F; Bertaccini G
Br J Pharmacol; 1996 Aug; 118(7):1813-21. PubMed ID: 8842448
[TBL] [Abstract][Full Text] [Related]
14. Ranitidine and other H2-receptor antagonists: recent developments.
Daly MJ; Price BJ
Prog Med Chem; 1983; 20():337-68. PubMed ID: 6138817
[No Abstract] [Full Text] [Related]
15. [Synthesis and H2-antihistaminic effect of N,N'-bisheteroaryl N,N'-bisheteroaryl-substituted cyanoguanidines and 2-nitro-1,1-ethenediamines. 17. H2-antihistaminics].
Borchers A; Postius S; Szelenyi I; Schunack W
Arzneimittelforschung; 1984; 34(7):751-4. PubMed ID: 6149751
[TBL] [Abstract][Full Text] [Related]
16. JB-9322, a new selective histamine H2-receptor antagonist with potent gastric mucosal protective properties.
Palacios B; Montero MJ; Sevilla MA; Román LS
Br J Pharmacol; 1995 May; 115(1):57-66. PubMed ID: 7647984
[TBL] [Abstract][Full Text] [Related]
17. A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.
Cavanagh RL; Usakewicz JJ; Buyniski JP
J Pharmacol Exp Ther; 1983 Jan; 224(1):171-9. PubMed ID: 6129316
[TBL] [Abstract][Full Text] [Related]
18. Pharmacology of ORF 17578, a new histamine H2-receptor antagonist: comparison with cimetidine and ranitidine.
Katz LB; Scott CK; Shriver DA
J Pharmacol Exp Ther; 1986 May; 237(2):404-10. PubMed ID: 2871172
[TBL] [Abstract][Full Text] [Related]
19. In vitro actions of ranitidine, a new histamine H2-receptor antagonist.
Daly MJ; Stables R
Agents Actions; 1980 Apr; 10(1 Pt 2):190-1. PubMed ID: 6104417
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the H2 receptor antagonist and gastric acid antisecretory properties of Wy-45,727.
Nielsen ST
J Pharmacol Exp Ther; 1987 Aug; 242(2):607-13. PubMed ID: 2886646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
